223 related articles for article (PubMed ID: 36893672)
1. Anti-inflammatory effect of Danhong injection through inhibition of GSDMD-mediated pyroptosis.
Li Y; Tu Z; Chen F; Yang X; Deng R; Su F; Cheng Z; Li S; Ong SB; Wang D; Chen Y; Xiang Y
Phytomedicine; 2023 May; 113():154743. PubMed ID: 36893672
[TBL] [Abstract][Full Text] [Related]
2. Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory response.
Yang W; Wang Y; Huang Y; Wang T; Li C; Zhang P; Liu W; Yin Y; Li R; Tao K
Inflammopharmacology; 2024 Feb; 32(1):419-432. PubMed ID: 37470905
[TBL] [Abstract][Full Text] [Related]
3. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation.
Hu JJ; Liu X; Xia S; Zhang Z; Zhang Y; Zhao J; Ruan J; Luo X; Lou X; Bai Y; Wang J; Hollingsworth LR; Magupalli VG; Zhao L; Luo HR; Kim J; Lieberman J; Wu H
Nat Immunol; 2020 Jul; 21(7):736-745. PubMed ID: 32367036
[TBL] [Abstract][Full Text] [Related]
4. Investigation on the mechanism of mafenide in inhibiting pyroptosis and the release of inflammatory factors.
Han C; Yang Y; Yu A; Guo L; Guan Q; Shen H; Jiao Q
Eur J Pharm Sci; 2020 Apr; 147():105303. PubMed ID: 32173407
[TBL] [Abstract][Full Text] [Related]
5. Polyunsaturated fatty acid-derived lipid mediator Resolvin D1 alleviates sepsis-induced disseminated intravascular coagulation via Caspase-1/Gasdermin D pyroptotic pathway.
Zhang W; Bhandari S; Ding Y; Luo J; Feng B; Jiang Y; Chen T; Wei J; Pan X; Weng H; Ding Z; Chen J; Chen X; Gong Y; Li H; Jin S; Hao Y
Clin Nutr; 2024 Jun; 43(6):1372-1383. PubMed ID: 38678822
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gasdermin D palmitoylation by disulfiram is crucial for the treatment of myocardial infarction.
Zhuang Z; Gu J; Li BO; Yang L
Transl Res; 2024 Feb; 264():66-75. PubMed ID: 37769810
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Small Molecule with Strong Anti-Inflammatory Activity in Experimental Autoimmune Encephalomyelitis and Sepsis through Blocking Gasdermin D Activation.
Cao R; Li Z; Wu C; Ji S; Li Y; Cao X; Dong X; Jiang M; Pang T; Wang C; Li J; Xu Y; Zhang CJ
J Immunol; 2022 Aug; 209(4):820-828. PubMed ID: 35906000
[TBL] [Abstract][Full Text] [Related]
8. Acinar cell NLRP3 inflammasome and gasdermin D (GSDMD) activation mediates pyroptosis and systemic inflammation in acute pancreatitis.
Gao L; Dong X; Gong W; Huang W; Xue J; Zhu Q; Ma N; Chen W; Fu X; Gao X; Lin Z; Ding Y; Shi J; Tong Z; Liu T; Mukherjee R; Sutton R; Lu G; Li W
Br J Pharmacol; 2021 Sep; 178(17):3533-3552. PubMed ID: 33871879
[TBL] [Abstract][Full Text] [Related]
9. Live-cell visualization of gasdermin D-driven pyroptotic cell death.
Rathkey JK; Benson BL; Chirieleison SM; Yang J; Xiao TS; Dubyak GR; Huang AY; Abbott DW
J Biol Chem; 2017 Sep; 292(35):14649-14658. PubMed ID: 28726636
[TBL] [Abstract][Full Text] [Related]
10. Gasdermin D is involved in switching from apoptosis to pyroptosis in TLR4-mediated renal tubular epithelial cells injury in diabetic kidney disease.
Yuan S; Wang Y; Li Z; Chen X; Song P; Chen A; Qu Z; Wen S; Liu H; Zhu X
Arch Biochem Biophys; 2022 Sep; 727():109347. PubMed ID: 35809639
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway.
Yang Y; Liu PY; Bao W; Chen SJ; Wu FS; Zhu PY
BMC Cancer; 2020 Jan; 20(1):28. PubMed ID: 31924176
[TBL] [Abstract][Full Text] [Related]
12. The gasdermin family: emerging therapeutic targets in diseases.
Zhu C; Xu S; Jiang R; Yu Y; Bian J; Zou Z
Signal Transduct Target Ther; 2024 Apr; 9(1):87. PubMed ID: 38584157
[TBL] [Abstract][Full Text] [Related]
13. Pyroptosis inhibiting nanobodies block Gasdermin D pore formation.
Kopp A; Hagelueken G; Jamitzky I; Moecking J; Schiffelers LDJ; Schmidt FI; Geyer M
Nat Commun; 2023 Dec; 14(1):7923. PubMed ID: 38040708
[TBL] [Abstract][Full Text] [Related]
14. Impairing Gasdermin D-mediated pyroptosis is protective against retinal degeneration.
Sekar R; Wooff Y; Cioanca AV; Kurera M; Ngo C; Man SM; Natoli R
J Neuroinflammation; 2023 Oct; 20(1):239. PubMed ID: 37864169
[TBL] [Abstract][Full Text] [Related]
15. Gasdermin D-mediated hepatocyte pyroptosis expands inflammatory responses that aggravate acute liver failure by upregulating monocyte chemotactic protein 1/CC chemokine receptor-2 to recruit macrophages.
Li H; Zhao XK; Cheng YJ; Zhang Q; Wu J; Lu S; Zhang W; Liu Y; Zhou MY; Wang Y; Yang J; Cheng ML
World J Gastroenterol; 2019 Nov; 25(44):6527-6540. PubMed ID: 31802832
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc modification of GSDMD attenuates LPS-induced endothelial cells pyroptosis.
Yu F; Zhang Z; Leng Y; Chen AF
Inflamm Res; 2024 Jan; 73(1):5-17. PubMed ID: 37962578
[TBL] [Abstract][Full Text] [Related]
17. Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular Mechanisms and Pharmacological Implications.
Liu Z; Chen Y; Mei Y; Yan M; Liang H
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067543
[TBL] [Abstract][Full Text] [Related]
18. RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis.
Chen H; Li Y; Wu J; Li G; Tao X; Lai K; Yuan Y; Zhang X; Zou Z; Xu Y
Cell Death Differ; 2020 Sep; 27(9):2568-2585. PubMed ID: 32152555
[TBL] [Abstract][Full Text] [Related]
19. CHMP4B and VSP4A reverse GSDMD-mediated pyroptosis by cell membrane remodeling in endometrial carcinoma.
Yang Y; Chen HL; Wu SF; Bao W
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130497. PubMed ID: 37931722
[TBL] [Abstract][Full Text] [Related]
20. Gasdermin D-Mediated Pyroptosis Promotes the Development of Atherosclerosis.
Huang B; Zou Z; Li Y; Chen H; Lai K; Yuan Y; Xu Y
Lab Invest; 2024 Apr; 104(4):100337. PubMed ID: 38266921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
